NewLimit is a biotechnology company dedicated to extending human healthspan through the development of epigenome-reprogramming medicines. Utilizing functional genomics, pooled perturbation screening, and machine learning, NewLimit aims to restore regenerative potential in aged and diseased cells, offering a novel therapeutic approach to age-related diseases.
NewLimit is a biotechnology company focused on extending human healthspan by reprogramming the epigenome. They are seeking a scientist with experience in endothelial biology to join their Vascular therapeutic team, developing assays and pre-clinical models to measure endothelial cell function and engineer nucleic acid delivery methods for targeting aging endothelial cells. This role involves collaboration with technology teams and analyzing experimental data to inform decision-making.
NewLimit is a biotechnology company dedicated to extending human healthspan through the development of epigenome-reprogramming medicines. Utilizing functional genomics, pooled perturbation screening, and machine learning, NewLimit aims to restore regenerative potential in aged and diseased cells, offering a novel therapeutic approach to age-related diseases.
NewLimit